Demczuk W, Sidhu S, Unemo M, Whiley D M, Allen V G, Dillon J R, Cole M, Seah C, Trembizki E, Trees D L, Kersh E N, Abrams A J, de Vries H J C, van Dam A P, Medina I, Bharat A, Mulvey M R, Van Domselaar G, Martin I
Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB, Canada.
WHO Collaborating Centre for Gonorrhoea and Other STIs, Örebro University Hospital, Örebro, Sweden.
J Clin Microbiol. 2017 May;55(5):1454-1468. doi: 10.1128/JCM.00100-17. Epub 2017 Feb 22.
A curated Web-based user-friendly sequence typing tool based on antimicrobial resistance determinants in was developed and is publicly accessible (https://ngstar.canada.ca). The Sequence Typing for Antimicrobial Resistance (NG-STAR) molecular typing scheme uses the DNA sequences of 7 genes (, , , , , , and 23S rRNA) associated with resistance to β-lactam antimicrobials, macrolides, or fluoroquinolones. NG-STAR uses the entire sequence, combining the historical nomenclature for types I to XXXVIII with novel nucleotide sequence designations; the full sequence and a portion of its promoter region; portions of , , , and ; and 23S rRNA sequences. NG-STAR grouped 768 isolates into 139 sequence types (STs) ( = 660) consisting of 29 clonal complexes (CCs) having a maximum of a single-locus variation, and 76 NG-STAR STs ( = 109) were identified as unrelated singletons. NG-STAR had a high Simpson's diversity index value of 96.5% (95% confidence interval [CI] = 0.959 to 0.969). The most common STs were NG-STAR ST-90 ( = 100; 13.0%), ST-42 and ST-91 ( = 45; 5.9%), ST-64 ( = 44; 5.72%), and ST-139 ( = 42; 5.5%). Decreased susceptibility to azithromycin was associated with NG-STAR ST-58, ST-61, ST-64, ST-79, ST-91, and ST-139 ( = 156; 92.3%); decreased susceptibility to cephalosporins was associated with NG-STAR ST-90, ST-91, and ST-97 ( = 162; 94.2%); and ciprofloxacin resistance was associated with NG-STAR ST-26, ST-90, ST-91, ST-97, ST-150, and ST-158 ( = 196; 98.0%). All isolates of NG-STAR ST-42, ST-43, ST-63, ST-81, and ST-160 ( = 106) were susceptible to all four antimicrobials. The standardization of nomenclature associated with antimicrobial resistance determinants through an internationally available database will facilitate the monitoring of the global dissemination of antimicrobial-resistant strains.
开发了一种基于网络的、用户友好的、经过整理的序列分型工具,该工具基于抗菌药物耐药性决定因素,并且可公开访问(https://ngstar.canada.ca)。抗菌药物耐药性的NG-STAR分子分型方案使用与β-内酰胺类抗菌药物、大环内酯类或氟喹诺酮类耐药性相关的7个基因(blaOXA、blaTEM、blaSHV、mecA、gyrA、parC和23S rRNA)的DNA序列。NG-STAR使用整个blaOXA序列,将I型至XXXVIII型的历史命名法与新的核苷酸序列命名法相结合;完整的mecA序列及其启动子区域的一部分;gyrA、parC、mecA和blaTEM的部分序列;以及23S rRNA序列。NG-STAR将768株分离株分为139个序列类型(STs)(n = 660),其中包括29个克隆复合体(CCs),最多有单一位点变异,并且76个NG-STAR STs(n = 109)被鉴定为不相关的单株。NG-STAR的辛普森多样性指数值很高,为96.5%(95%置信区间[CI] = 0.959至0.969)。最常见的STs是NG-STAR ST-90(n = 100;13.0%)、ST-42和ST-91(n = 45;5.9%)、ST-64(n = 44;5.72%)和ST-139(n = 42;5.5%)。对阿奇霉素敏感性降低与NG-STAR ST-58、ST-61、ST-64、ST-79、ST-91和ST-139相关(n = 156;92.3%);对头孢菌素敏感性降低与NG-STAR ST-90、ST-91和ST-97相关(n = 162;94.2%);环丙沙星耐药性与NG-STAR ST-26、ST-90、ST-91、ST-97、ST-150和ST-158相关(n = 196;98.0%)。NG-STAR ST-42、ST-43、ST-63、ST-81和ST-160的所有分离株(n = 106)对所有四种抗菌药物均敏感。通过一个国际可用数据库实现与抗菌药物耐药性决定因素相关的命名标准化,将有助于监测耐抗菌药物肺炎克雷伯菌菌株在全球的传播情况。